Net Widens for Companies Over Tainted Valsartan Recalls Net Widens for Companies Over Tainted Valsartan Recalls

The FDA reports that several additional companies that repackage drug products are also recalling products containing the heart drug valsartan, and it says more recalls are likely.Medscape Medical News

Source: Medscape Medical News Headlines - July 30, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news